SCHEMBL30906355

SCHEMBL30906355

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 8/20 0.52
▸ BACE2 Q9Y5Z0 3/20 0.50
▸ VIPR2 P41587 5/20 0.49
▸ OPRD1 P41143 1/20 0.49
▸ VIPR1 P32241 4/20 0.48
▸ CTSD P07339 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30906565 0.95 BACE1 (0.52) BACE1BACE2VIPR2OPRD1VIPR1
SCHEMBL30906454 0.91 BACE1 (0.49) BACE1BACE2OPRD1CTSD
SCHEMBL30906568 0.90 BACE1 (0.54) BACE1BACE2VIPR2OPRD1VIPR1
SCHEMBL30906333 0.88 CALCR (0.56) —
SCHEMBL30512663 0.86 BACE1 (0.51) BACE1BACE2OPRD1
SCHEMBL29903284 0.86 VIPR1 (0.58) VIPR2VIPR1
SCHEMBL29903357 0.84 VIPR1 (0.54) BACE1BACE2VIPR2VIPR1
SCHEMBL30607469 0.83 BACE1 (0.51) BACE1BACE2VIPR2OPRD1CTSD
SCHEMBL30512568 0.83 BACE1 (0.64) BACE1BACE2VIPR2OPRD1VIPR1
SCHEMBL29655823 0.83 ENPEP (0.52) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598964-A2 ANTI-IGE ANTIBODIES Abwiz Bio, Inc. (US) 2025-08-13 — — EP disclosed
US-20240182599-A1 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. 2024-06-06 — — US disclosed
WO-2024076785-A2 ANTI-IGE ANTIBODIES ABWIZ BIO, INC. (US) 2024-04-11 — — WO disclosed
Send feedback